En savoir plus sur le livre
The Encyclopedia of Heart Diseases is an accurate and reliable source of in-depth information on the diseases that kill more than 12 million individuals worldwide each year. Cardiovascular diseases are more prevalent than the combined incidence of all forms of cancer, diabetes, asthma, and leukemia. This encyclopedia thoroughly covers these ailments and includes in-depth analysis of less common and rare heart conditions. Researchers, clinicians, and students will find this resource an invaluable tool for quick reference before approaching the primary literature. Coverage includes more than 200 topics, including applied pharmacology of current and experimental cardiac drugs, gene therapy, MRI, electron-beam CT, PET scan, cardiac tests costs and justification, and new frontiers in cardiovascular research.
Achat du livre
Encyclopedia of Heart Diseases, M. I. Gabriel Khan
- Langue
- Année de publication
- 2010
- product-detail.submit-box.info.binding
- (rigide)
Modes de paiement
Personne n'a encore évalué .
- Titre
- Encyclopedia of Heart Diseases
- Langue
- Anglais
- Auteurs
- M. I. Gabriel Khan
- Publié
- 2010
- Format
- rigide
- Pages
- 922
- ISBN10
- 1607612186
- ISBN13
- 9781607612186
- Séries
- Mots clés
- Nonfiction, Santé & Médecine, Médecine
- Description
- The Encyclopedia of Heart Diseases is an accurate and reliable source of in-depth information on the diseases that kill more than 12 million individuals worldwide each year. Cardiovascular diseases are more prevalent than the combined incidence of all forms of cancer, diabetes, asthma, and leukemia. This encyclopedia thoroughly covers these ailments and includes in-depth analysis of less common and rare heart conditions. Researchers, clinicians, and students will find this resource an invaluable tool for quick reference before approaching the primary literature. Coverage includes more than 200 topics, including applied pharmacology of current and experimental cardiac drugs, gene therapy, MRI, electron-beam CT, PET scan, cardiac tests costs and justification, and new frontiers in cardiovascular research.